The current price of PGEN is $4.03 — it has decreased by 20.38% since the previous close. Data as of Nov 5, 2026.
PGEN is down 38.44% over the past week, down 48.39% over the past month and up 0.13% over the past year. The price is below its 200-day moving average of $5.28.
Analysts' average 12-month price target for PGEN is $15.00, which implies 272.67% upside from the current price. Individual estimates range from $12.00 to $18.00.
Of the 4 analysts covering Precigen, Inc., 1 rates it a strong buy, 2 rate it a buy and 1 rates it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Precigen, Inc. has a market capitalization of $1.44B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In the latest trading session PGEN moved between $3.92 and $4.74, a range of 20.37% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Precigen, Inc. shows a strong sell rating today and a sell rating on the weekly timeframe. Technical ratings are indicators, not investment advice.
Over the past 52 weeks PGEN has traded between $3.04 and $8.98. The current price is 55.18% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.